Research Collaboration
One hallmark of Dana-Farber/Brigham and Women's Cancer Center is the close integration between the clinical care of our patients and our research labs, with each informing the other. The introduction of genomics has accelerated this process and has already led to dramatic advances in our understanding of the causes and makeup of cancer, and most importantly, to exciting new “personalized” therapies for the benefit of our patients.
The mapping of the human genome advanced our understanding of the genetic alterations associated with different cancers. Scientists can now interrogate each individual’s specific cancer, and consequently, have uncovered many of cancer’s underlying causes and behavior.
Learn More
Profile, a research project